U.S. Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu-Chek Inform II, Freestyle Lite, True Metrix, i-STAT, StatStrip, Onetouch Verio Flex, Bayer CONTOUR Blood Glucose Monitoring System), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product
                        1.1.2. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective - 1
                        1.9.2. Objective - 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                    2.3. Competitive Insights
Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Industry Value Chain Analysis
                        3.3.1. Reimbursement framework
                    3.4. Market Dynamics
                        3.4.1. Market driver analysis
                            3.4.1.1. Introduction of CLIA waived tests
                            3.4.1.2. Growing prevalence of diabetes
                            3.4.1.3. Rising demand for short turnaround time glucose POC testing
                        3.4.2. Market restraint analysis
                            3.4.2.1. Potential interference and calibration issues in glucose meters
                            3.4.2.2. Presence of ambiguous regulatory as well as reimbursement framework
                    3.5. Point-of-Care(POC) Glucose Testing Market Analysis Tools
                        3.5.1. Industry Analysis - Porter’s Five Forces
                            3.5.1.1. Supplier power
                            3.5.1.2. Buyer power
                            3.5.1.3. Substitution threat
                            3.5.1.4. Threat of new entrant
                            3.5.1.5. Competitive rivalry
                        3.5.2. PESTEL Analysis
                            3.5.2.1. Political landscape
                            3.5.2.2. Technological landscape
                            3.5.2.3. Economic landscape
                        3.5.3. Major Deals & Strategic Alliances Analysis
                        3.5.4. Market Entry Strategies
Chapter 4. U.S. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis
                    4.1. Definitions and Scope
                    4.2. Product Market Share, 2018 & 2030
                    4.3. Segment Dashboard
                    4.4. U.S. Point-of-Care (POC) Glucose Testing Market by Product Outlook
                    4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.5.1. Accu-Check Aviva Meter
                            4.5.1.1. Accu-Check Aviva Meter market estimates and forecast, 2018 - 2030
                        4.5.2. Onetouch Verio Flex
                            4.5.2.1. Onetouch Verio Flex market estimates and forecast, 2018 - 2030
                        4.5.3. i-STAT
                            4.5.3.1. I-STAT market estimates and forecast, 2018 - 2030
                        4.5.4. Freestyle Lite
                            4.5.4.1. Freestyle Lite market estimates and forecast, 2018 - 2030
                        4.5.5. Bayer Contour Blood Glucose Monitoring System
                            4.5.5.1. Bayer Contour Blood Glucose Monitoring System market estimates and forecast, 2018 - 2030
                        4.5.6. True Metrix
                            4.5.6.1. TRUE METRIX market estimates and forecast, 2018 - 2030
                        4.5.7. Accu-Check Inform II
                            4.5.7.1. Accu-Check Inform II market estimates and forecast, 2018 - 2030
                        4.5.8. StatStrip
                            4.5.8.1. StatStrip market estimates and forecast, 2018 - 2030
                        4.5.9. Others
                            4.5.9.1. Others market estimates and forecast, 2018 - 2030
Chapter 5. Competitive Landscape
                    5.1. Recent Developments & Impact Analysis, By Key Market Participants
                    5.2. Company/Competition Categorization
                        5.2.1. Innovators
                    5.3. Vendor Landscape
                        5.3.1. List of key distributors and channel partners
                        5.3.2. Key customers
                        5.3.3. Key company market share analysis, 2021
                        5.3.4. F. Hoffmann-La Roche Ltd.
                            5.3.4.1. Company overview
                            5.3.4.2. Financial performance
                            5.3.4.3. Product benchmarking
                            5.3.4.4. Strategic initiatives
                        5.3.5. Abbott
                            5.3.5.1. Company overview
                            5.3.5.2. Financial performance
                            5.3.5.3. Product benchmarking
                            5.3.5.4. Strategic initiatives
                        5.3.6. Nipro
                            5.3.6.1. Company overview
                            5.3.6.2. Financial performance
                            5.3.6.3. Product benchmarking
                            5.3.6.4. Strategic initiatives
                        5.3.7. Platinum Equity Advisors, LLC (Lifescan, Inc.)
                            5.3.7.1. Company overview
                            5.3.7.2. Financial performance
                            5.3.7.3. Product benchmarking
                            5.3.7.4. Strategic initiatives
                        5.3.8. Nova Biomedical
                            5.3.8.1. Company overview
                            5.3.8.2. Financial performance
                            5.3.8.3. Product benchmarking
                            5.3.8.4. Strategic initiatives
                        5.3.9. ACON Laboratories
                            5.3.9.1. Company overview
                            5.3.9.2. Financial performance
                            5.3.9.3. Product benchmarking
                            5.3.9.4. Strategic initiatives
                        5.3.10. Trividia Health, Inc.
                            5.3.10.1. Company overview
                            5.3.10.2. Financial performance
                            5.3.10.3. Product benchmarking
                            5.3.10.4. Strategic initiatives
                        5.3.11. Prodigy Diabetes Care, LLC
                            5.3.11.1. Company overview
                            5.3.11.2. Financial performance
                            5.3.11.3. Product benchmarking
                            5.3.11.4. Strategic initiatives
                        5.3.12. Bayer AG/Ascensia Diabetes Care Holdings AG
                            5.3.12.1. Company overview
                            5.3.12.2. Financial performance
                            5.3.12.3. Product benchmarking
                            5.3.12.4. Strategic initiatives
                        5.3.13. EKF Diagnostics
                            5.3.13.1. Company overview
                            5.3.13.2. Financial performance
                            5.3.13.3. Product benchmarking
                            5.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research interviews
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Point-of-Care (POC) Glucose Testing market: market outlook
Fig. 9 Point-of-Care (POC) Glucose Testing market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Point-of-Care (POC) Glucose Testing market driver impact
Fig. 15 Point-of-Care (POC) Glucose Testing market restraint impact
Fig. 16 Point-of-Care (POC) Glucose Testing market strategic initiatives analysis
Fig. 17 Point-of-Care (POC) Glucose Testing market: product movement analysis
Fig. 18 Point-of-Care (POC) Glucose Testing market: product outlook and key takeaways
Fig. 19 Accu Check Aviva meter market estimates and forecast, 2018 - 2030
Fig. 20 Onetouch Verio Flex market estimates and forecast, 2018 - 2030
Fig. 21 i-STAT market estimates and forecast, 2018 - 2030
Fig. 22 Freestyle Lite market estimates and forecast, 2018 - 2030
Fig. 23 Bayer CONTOUR blood glucose monitoring system market estimates and forecast, 2018 - 2030
Fig. 24 True Metrix market estimates and forecast, 2018 - 2030
Fig. 25 Accu-Chek Inform II market estimates and forecast, 2018 - 2030
Fig. 26 StatStrip market estimates and forecast, 2018 - 2030
Fig. 27 Other market estimates and forecast, 2018 - 2030
Fig. 28 Participant categorization- Point-of-Care (POC) Glucose Testing market
Fig. 29 Market share of key market players- Point-of-Care (POC) Glucose Testing market